These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 26560689)
1. Current concepts and future potential in neoadjuvant chemotherapy for esophageal cancer. Blum Murphy MA; Elimova E; Ajani JA Expert Rev Gastroenterol Hepatol; 2016; 10(3):383-92. PubMed ID: 26560689 [TBL] [Abstract][Full Text] [Related]
2. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm. Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797 [TBL] [Abstract][Full Text] [Related]
4. Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients. Hoeppner J; Zirlik K; Brunner T; Bronsert P; Kulemann B; Sick O; Marjanovic G; Hopt UT; Makowiec F J Surg Oncol; 2014 Mar; 109(3):287-93. PubMed ID: 24277235 [TBL] [Abstract][Full Text] [Related]
5. [Multimodality therapy concepts in esophageal carcinoma]. Siewert JR; Ott K Kongressbd Dtsch Ges Chir Kongr; 2001; 118():39-43. PubMed ID: 11824282 [TBL] [Abstract][Full Text] [Related]
6. Comparison of survival among neoadjuvant chemoradiation responders, non-responders and patients receiving primary resection for locally advanced oesophageal squamous cell carcinoma: does neoadjuvant chemoradiation benefit all? Hsu PK; Chien LI; Huang CS; Hsieh CC; Wu YC; Hsu WH; Chou TY Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):460-6. PubMed ID: 23728085 [TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution. Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354 [TBL] [Abstract][Full Text] [Related]
8. The current status of neoadjuvant therapy for esophageal cancer. Lin D; Leichman L Semin Thorac Cardiovasc Surg; 2014; 26(2):102-9. PubMed ID: 25441001 [TBL] [Abstract][Full Text] [Related]
9. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma. Cao XF; He XT; Ji L; Xiao J; Lv J Dis Esophagus; 2009; 22(6):477-81. PubMed ID: 19703071 [TBL] [Abstract][Full Text] [Related]
10. Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study. Markar SR; Gronnier C; Pasquer A; Duhamel A; Beal H; Théreaux J; Gagnière J; Lebreton G; Brigand C; Meunier B; Collet D; Mariette C; Eur J Cancer; 2016 Mar; 56():59-68. PubMed ID: 26808298 [TBL] [Abstract][Full Text] [Related]
11. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients]. Imdahl A; Schöffel U; Ruf G; Hopf UT Zentralbl Chir; 2004 Oct; 129(5):350-5. PubMed ID: 15486784 [TBL] [Abstract][Full Text] [Related]
12. Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma. Saeki H; Nakashima Y; Zaitsu Y; Tsuda Y; Kasagi Y; Ando K; Imamura Y; Ohgaki K; Ito S; Kimura Y; Egashira A; Oki E; Morita M; Maehara Y Surg Today; 2016 Mar; 46(3):261-7. PubMed ID: 25740123 [TBL] [Abstract][Full Text] [Related]
13. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Mariette C; Taillier G; Van Seuningen I; Triboulet JP Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466 [TBL] [Abstract][Full Text] [Related]
14. What is the optimal interval between chemoradiation and esophagectomy? Martin LW Semin Thorac Cardiovasc Surg; 2012; 24(2):87-9. PubMed ID: 22920522 [TBL] [Abstract][Full Text] [Related]
15. [Neoadjuvant therapy in oesophageal cancer surgery]. Imdahl A Zentralbl Chir; 2006 Apr; 131(2):105-9. PubMed ID: 16612775 [TBL] [Abstract][Full Text] [Related]
16. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma. Higuchi I; Yasuda T; Yano M; Doki Y; Miyata H; Tatsumi M; Fukunaga H; Takiguchi S; Fujiwara Y; Hatazawa J; Monden M J Thorac Cardiovasc Surg; 2008 Jul; 136(1):205-12, 212.e1-3. PubMed ID: 18603077 [TBL] [Abstract][Full Text] [Related]
17. Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer. Stiles BM; Christos P; Port JL; Lee PC; Paul S; Saunders J; Altorki NK J Thorac Cardiovasc Surg; 2010 Feb; 139(2):387-94. PubMed ID: 20006355 [TBL] [Abstract][Full Text] [Related]
18. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction. Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330 [TBL] [Abstract][Full Text] [Related]
19. Esophagectomy after chemoradiation: who and when to operate. Kim JY; Hofstetter WL Semin Thorac Cardiovasc Surg; 2012; 24(4):288-93. PubMed ID: 23465677 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the prognostic value of the 6th and 7th editions of the Union for International Cancer Control TNM staging system in patients with lower esophageal cancer undergoing neoadjuvant chemotherapy followed by surgery. Mehta SP; Jose P; Mirza A; Pritchard SA; Hayden JD; Grabsch HI Dis Esophagus; 2013; 26(2):182-8. PubMed ID: 22591020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]